Contact:
Tel: +32(0) 10 39 41 00
Fax: +32(0) 10 39 41 41
Email: info@celyad.com
(C) 2023 Electronic News Publishing, source
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 EUR | 0.00% | -6.06% | -20.51% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
Contact:
Tel: +32(0) 10 39 41 00
Fax: +32(0) 10 39 41 41
Email: info@celyad.com
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-20.51% | 13.74M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.90% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |